Biotechnology Small-Cap Cancer Drug Developer Agenus’ Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns Loom – Agenus (NASDAQ:AGEN) Read more
Biotechnology Small-Cap Firm Century Therapeutics’ Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing – Century Therapeutics (NASDAQ:IPSC) Read more